WO2008068727A3 - Pharmaceutical composition comprising candesartan cilexetil - Google Patents

Pharmaceutical composition comprising candesartan cilexetil

Info

Publication number
WO2008068727A3
WO2008068727A3 PCT/IB2007/054958 IB2007054958W WO2008068727A3 WO 2008068727 A3 WO2008068727 A3 WO 2008068727A3 IB 2007054958 W IB2007054958 W IB 2007054958W WO 2008068727 A3 WO2008068727 A3 WO 2008068727A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
pharmaceutical composition
candesartan cilexetil
cilexetil
candesartan
present invention
Prior art date
Application number
PCT/IB2007/054958
Other languages
French (fr)
Other versions
WO2008068727A2 (en )
Inventor
Ajay Kumar Handa
Swargam Sathyanarayana
Ajay Kumar Singla
Original Assignee
Ajay Kumar Handa
Ranbaxy Lab Ltd
Swargam Sathyanarayana
Ajay Kumar Singla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Abstract

The present invention relates to a pharmaceutical composition comprising candesartan cilexetil.
PCT/IB2007/054958 2006-12-06 2007-12-06 Pharmaceutical composition comprising candesartan cilexetil WO2008068727A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN2618/DEL/2006 2006-12-06
IN2618DE2006 2006-12-06

Publications (2)

Publication Number Publication Date
WO2008068727A2 true WO2008068727A2 (en) 2008-06-12
WO2008068727A3 true true WO2008068727A3 (en) 2008-12-31

Family

ID=39410128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/054958 WO2008068727A3 (en) 2006-12-06 2007-12-06 Pharmaceutical composition comprising candesartan cilexetil

Country Status (1)

Country Link
WO (1) WO2008068727A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2014119667A1 (en) * 2013-01-30 2017-01-26 沢井製薬株式会社 Candesartan cilexetil pharmaceutical composition containing

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006126A1 (en) * 1998-07-28 2000-02-10 Takeda Chemical Industries, Ltd. Rapidly disintegrable solid preparation
EP1203580A1 (en) * 1999-06-18 2002-05-08 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
WO2005070398A2 (en) * 2004-01-23 2005-08-04 Ranbaxy Laboratories Limited Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents
WO2005084648A1 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited Pharmaceutical compositions comprising candesartan cilexetil

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006126A1 (en) * 1998-07-28 2000-02-10 Takeda Chemical Industries, Ltd. Rapidly disintegrable solid preparation
EP1203580A1 (en) * 1999-06-18 2002-05-08 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
WO2005070398A2 (en) * 2004-01-23 2005-08-04 Ranbaxy Laboratories Limited Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents
WO2005084648A1 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited Pharmaceutical compositions comprising candesartan cilexetil

Also Published As

Publication number Publication date Type
WO2008068727A2 (en) 2008-06-12 application

Similar Documents

Publication Publication Date Title
WO2007017423A3 (en) Pharmaceutical composition comprising a dpp-iv inhibitor
GB0607840D0 (en) Novel compounds
EP2133094A4 (en) Pharmaceutical composition
GB2435470B (en) Agricultural composition
GB0819432D0 (en) Compound, composition and use
GB0624901D0 (en) Novel compounds E
GB0513692D0 (en) Novel pharmaceutical compositions
GB0505693D0 (en) Novel pharmaceutical compositions
GB0513693D0 (en) Novel pharmaceutical compositions
GB0512202D0 (en) Novel pharmaceutical compositions
GB0702326D0 (en) Hydroxybenzophenone derivatives
GB0623603D0 (en) Mpa
GB0616496D0 (en) A sanitary composition
GB2444823B (en) Chemically amplified resist composition
GB0725099D0 (en) Chemically amplified resist composition
GB2446687B (en) Chemically amplified resist composition
GB0518166D0 (en) Pharmaceutical composition
GB0504276D0 (en) Pharmaceutical composition
GB0511801D0 (en) Pharmaceutical composition
GB0500138D0 (en) Pharmaceutical composition
GB0712558D0 (en) Pharmaceutical composition
GB2442823B (en) Deairling type hydraulic tensioner
GB0819507D0 (en) Aqueous primer composition
GB0608095D0 (en) Novel compounds A3
GB0610221D0 (en) Novel structures

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07849366

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 07849366

Country of ref document: EP

Kind code of ref document: A2